Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Bad Vöslau – page 21

865 clinical trials in Bad Vöslau, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Bad Vöslau at a glance
865
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

865 trials in Bad Vöslau

Open in trial search

Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Crisantaspase
  • Sponsor:Pfizer Inc.

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn's Disease

Investigational
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan
  • Sponsor:Daiichi Sankyo Inc.

Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne

Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Swiss GO Trial Group

Study on the Effects of Adding Durvalumab After Chemotherapy and Surgery in Patients with Resectable Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:ETOP IBCSG Partners Foundation

Myelofibrosis

Recruiting

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.

Study on the Effects of Ticagrelor and Acetylsalicylic Acid in Patients with Coronary Artery Disease Undergoing CABG Surgery

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Weill Medical College Of Cornell University

Medulloblastoma

Recruiting

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:University Medical Center Hamburg-Eppendorf

Study of Tabelecleucel for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Transplant Treatment Failure

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tabelecleucel
  • Sponsor:Pierre Fabre Medicament

Breast cancer

Recruiting

Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Astrazeneca AB

Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tabelecleucel
  • Sponsor:Pierre Fabre Medicament

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Bad Vöslau

What the registry says about research in the country

01 Neuropathic Pain Studies

Investigating new treatment approaches for patients with diabetic polyneuropathy, focusing on innovative pain management solutions that could improve quality of life for those affected by chronic neuropathic conditions.

  • Diabetic Neuropathy Management
  • Chronic Pain Treatment
  • Add-on Therapy Evaluation

Research aims to enhance current treatment protocols for diabetes-related nerve pain.

02 Trauma-Related Neuropathy

Evaluating therapeutic options for patients experiencing post-operative and traumatic peripheral neuropathy, with a focus on developing effective pain management strategies for those affected by surgery or injury-related nerve damage.

  • Post-surgical Pain Management
  • Trauma-induced Neuropathy
  • Peripheral Nerve Pain

Studies explore innovative approaches to managing chronic pain resulting from surgical procedures and trauma.

03 Central Neuropathy Research

Examining treatment efficacy for central neuropathy of various origins, investigating novel therapeutic approaches for managing chronic pain associated with central nervous system conditions.

  • Central Nervous System Pain
  • Neurological Pain Management
  • Pain Relief Strategies

This research explores comprehensive treatment options for central nervous system-related pain conditions.

04 Chronic Back Pain Treatment

Investigating innovative therapies for patients suffering from chronic back pain, focusing on developing effective add-on treatments to enhance current pain management approaches.

  • Back Pain Management
  • Long-term Pain Relief
  • Therapeutic Advancement

Studies aim to improve treatment outcomes for individuals with persistent back pain conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.